Scedosporium and Lomentospora: an updated overview of underrated opportunists
Ikusi/ Ireki
Data
2018-04-01Egilea
Ramírez García, Andoni
Pellón Rodríguez, Aize
Rementeria Ruiz, Aitor Domingo
Buldain Garriz, Idoia
Barreto-Bergter, Eliana
Rollin-Pinheiro, Rodrigo
Vieira de Meirelles, Jardel
Xisto, Mariana Ingrid D. S.
Ranque, Stephane
Havlicek, Vladimir
Vandeputte, Patrick
Le Govic, Yohann
Bouchara, Jean Philippe
Giraud, Sandrine
Chen, Sharon
Rainer, Johannes
Alastruey-Izquierdo, Ana
Martín Gómez, María Teresa
López Soria, Leyre
Pemán, Javier
Schwarz, Carsten
Bernhardt, Anne
Tintelnot, Kathrin
Capilla, Javier
Martin-Vicente, Adela
Cano-Lira, Jose
Nagl, Markus
Lackner, Michaela
Irinyi, Laszlo
Meyer, Wieland
de Hoog, Sybren
Hernando, Fernando Luis
Medical Mycology 56(Sup.1) : S102–S125 (2018)
Laburpena
Species of Scedosporium and Lomentospora are considered as emerging opportunists, affecting immunosuppressed and otherwise debilitated patients, although classically they are known from causing trauma-associated infections in healthy individuals. Clinical manifestations range from local infection to pulmonary colonization and severe invasive disease, in which mortality rates may be over 80%. These unacceptably high rates are due to the clinical status of patients, diagnostic difficulties, and to intrinsic antifungal resistance of these fungi. In consequence, several consortia have been founded to increase research efforts on these orphan fungi. The current review presents recent findings and summarizes the most relevant points, including the Scedosporium/Lomentospora taxonomy, environmental distribution, epidemiology, pathology, virulence factors, immunology, diagnostic methods, and therapeutic strategies.